- The trend backdrop is active with a 3-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
- Activity pressure is constructive, supporting the smart-money activity read.
FAIRCHEMOR
NSI
Week ended 07 Aug 2026
Weekly Investor Report
Fairchem Organics Limited · Basic Materials · Specialty Chemicals
Latest close
750.0 INR
-5.9%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 21.2% above the Trend Line and sits at 73.0% of its 52-week range. The latest completed week returned -5.9%, after a 7.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers. The latest news-sentiment score is 58/100.
Setup score
57
out of 100
Latest Close
750.0 INR
7 Aug 2026
1W Return
-5.9%
latest completed week
4W Return
7.2%
short-term follow-through
12W Return
21.3%
quarterly tape
Trend Breadth
5.8%
3 of 52 weeks active
Volume Ratio
1.0x
vs 13-week average
- Price is below Fair Value, so the market is still discounting the latest tape.
- The latest week was a sharp negative move.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-5.9%
Latest completed week; four-week move 7.2%.
Indicator stack
14/79
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
58/100
13 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 21.2% above the Trend Line and sits at 73.0% of its 52-week range. The latest completed week returned -5.9%, after a 7.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5612-week average 0.27
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.56Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 7.2% over four weeks, 21.3% over 12 weeks, and -12.4% over one year. The current trend has remained active for 3 consecutive weeks.
Performance by holding period
Active trend streak3 weeks
Active weeks in one year3
Trend breadth5.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.42Latest activity-pressure read.
Pressure change40.2%Four-week change in activity pressure.
Leadership12.55Latest relative-leadership reading.
RS change151.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks weakly; valuation is expensive relative to peers.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 91%
Model confidence 85%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength4/100Blend of value, momentum, and quality. Underlying universe rank 97; rank 1 is best.
Value19/100Relative valuation strength. Underlying universe rank 82; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum26/100Medium-term price momentum. Underlying universe rank 75; rank 1 is best.
Growth2/100Revenue and earnings growth. Underlying universe rank 99; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework1/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 170.5x Price divided by trailing earnings.
- Price / sales
- 2.1x Market value relative to trailing revenue.
- EV / EBITDA
- 46.7x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 2.6% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 20.1% Gross profit retained from each unit of revenue.
- Operating margin
- 2.3% Operating profit retained from revenue.
- Free-cash-flow margin
- 5.7% Free cash flow generated from revenue.
- Return on invested capital
- 2.3% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- -14.5% Latest one-year revenue growth.
- EPS growth
- -73.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 4/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.1% Cash dividends relative to market value.
- Buyback yield
- 3.7% Net share repurchases relative to market value.
- Shareholder yield
- 3.9% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 3.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment58/100
Weighted news tone is neutral across 13 relevant articles.
2 positive · 10 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.7%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+14.9%Week of 3 Jul.
Worst week-7.4%Week of 20 Feb.
Latest week-5.9%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains7
Flat weeks0
Modest losses6
Sharp losses6
Recent vol5.3%13-week weekly-return volatility.
Base vol5.4%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew4.5% / -3.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank- / 100
Group average2.8%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD52.0%positive activity pressure
RS63.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank39 / 100
Group average5.8%
Trend breadth77.0%
Trend77.0%active weekly trend signals
MD75.0%positive activity pressure
RS72.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape51/100
Trend, activity pressure, participation, and risk combine to a 51/100 tape read.
Indicator analysis55/100Latest 12-week confirmation: trend 3/12, activity pressure 12/12, relative leadership 6/12.
Activity pressure 0.56; No reversal markers Factors15/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 2; Small Cap Core rank 68 SVQF1/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1567.0 of 1576 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment58/100Weighted news tone is neutral across 13 relevant articles.
Fairchem Organics net profit surges 751% in Q1FY27 on margin expansion Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 750.0 INR | -5.9% | 618.8 INR | 972.1 INR | 1.42 | 12.55 | 68.9K | On |
| 31 Jul 2026 | 797.1 INR | 3.8% | 617.5 INR | 973.7 INR | 1.45 | 20.15 | 333.8K | On |
| 24 Jul 2026 | 768.1 INR | 9.2% | 616.5 INR | 976.3 INR | 1.37 | 18.50 | 148.1K | On |
| 17 Jul 2026 | 703.2 INR | 0.5% | 614.2 INR | 978.7 INR | 1.18 | 5.66 | 37.9K | Off |
| 10 Jul 2026 | 699.5 INR | -3.9% | 613.6 INR | 981.7 INR | 1.01 | 4.99 | 33.3K | Off |
| 3 Jul 2026 | 727.7 INR | 14.9% | 613.0 INR | 985.0 INR | 0.84 | 8.19 | 44.2K | Off |
| 26 Jun 2026 | 633.5 INR | 4.2% | 611.7 INR | 988.3 INR | 0.68 | -5.53 | 0 | Off |
| 19 Jun 2026 | 608.0 INR | 2.7% | 612.4 INR | 992.0 INR | 0.75 | -9.78 | 3.9K | Off |
| 12 Jun 2026 | 592.2 INR | -2.2% | 614.5 INR | 996.0 INR | 0.79 | -11.42 | 6.9K | Off |
| 5 Jun 2026 | 605.5 INR | -1.7% | 615.9 INR | 1,000 INR | 0.90 | -9.23 | 2.3K | Off |
| 29 May 2026 | 616.2 INR | 0.4% | 620.3 INR | 1,005 INR | 1.04 | -9.05 | 89.6K | Off |
| 22 May 2026 | 613.9 INR | -0.7% | 625.0 INR | 1,009 INR | 0.81 | -10.50 | 66.5K | Off |
| 15 May 2026 | 618.0 INR | -0.2% | 629.8 INR | 1,013 INR | 0.49 | -10.06 | 79.7K | Off |
| 8 May 2026 | 619.4 INR | 8.5% | 634.8 INR | 1,016 INR | 0.13 | -12.20 | 211.3K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.